International phase I trial results of recombinant fusion protein linking coagulation Factor IX with albumin (rIX-FP) show all pharmaco-kinetic parameters significantly improved in patients with severe hemophilia B. Learn More
Entrepreneur with hemophilia B focuses on his goals. Read his story and others.
CSL Behring will donate FVIII concentrate to improve treatment in developing countries.
Choose and use a convenient Discussion Guide, to guide your conversation with doctors, teachers or employers.
Phase I trial showed “promising" half-life extension results.
Hear from thought leaders about making rare diseases a global priority.
Take a clear and simple look at the process of blood coagulation.
